Stock listing
NYSE:BHVN Biohaven Ltd. Stock
Home listing (NYSE) of Biohaven Ltd.
Follow Biohaven Ltd. into a list and get an email when it puts out news.
Share price · NYSE:BHVN
$11.75 USD -0.06 (-0.5%)
Close on Oct 21, 2026
- Day range
- $11.63 – $12.16 USDOct 21, 2026
- Volume
- 1.44M sharesOct 21, 2026
- Market cap
- $1.77B USDAt the close on Oct 21, 2026 · price × 151.0M shares outstanding

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE:BHVN · Home | $11.75 USD | -0.06 (-0.5%) | 1,443,706 | $11.90 | $12.16 | $11.63 | $11.81 | Close on Oct 21, 2026 |
Daily closes
Last 3 months, Jul 21, 2026 – Oct 21, 2026 · NYSE:BHVN · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $11.75 | -0.06 | -0.5% | $11.90 | $12.16 | $11.63 | 1,443,706 | |
| $11.81 | +0.46 | +4.1% | $11.35 | $11.84 | $11.07 | 1,506,125 | |
| $11.35 | +0.57 | +5.3% | $11.01 | $11.52 | $10.87 | 1,690,853 | |
| $10.78 | -0.65 | -5.7% | $11.31 | $11.40 | $10.71 | 2,423,654 | |
| $11.43 | +0.50 | +4.6% | $10.95 | $11.66 | $10.94 | 1,448,227 | |
| $10.93 | -0.49 | -4.3% | $11.39 | $11.50 | $10.82 | 1,776,817 | |
| $11.42 | -0.39 | -3.3% | $11.79 | $11.79 | $11.16 | 2,434,030 | |
| $11.81 | -0.27 | -2.2% | $11.91 | $11.99 | $11.65 | 1,623,227 | |
| $12.08 | +0.15 | +1.3% | $11.90 | $12.27 | $11.75 | 1,370,000 | |
| $11.93 | +0.05 | +0.4% | $11.83 | $12.12 | $11.46 | 2,698,600 | |
| $11.88 | -0.20 | -1.7% | $11.86 | $12.23 | $11.85 | 2,147,200 | |
| $12.08 | -0.89 | -6.9% | $13.00 | $13.04 | $11.88 | 3,054,000 | |
| $12.97 | +0.10 | +0.8% | $12.85 | $13.31 | $12.45 | 1,671,700 | |
| $12.87 | -0.27 | -2.1% | $13.41 | $13.51 | $12.63 | 1,735,500 | |
| $13.14 | -0.21 | -1.6% | $13.31 | $13.62 | $13.04 | 1,507,200 | |
| $13.35 | +0.06 | +0.5% | $13.50 | $13.63 | $13.21 | 1,432,100 | |
| $13.29 | +0.02 | +0.2% | $13.12 | $13.50 | $12.93 | 1,534,000 | |
| $13.27 | +0.28 | +2.2% | $12.82 | $13.42 | $12.49 | 2,046,000 | |
| $12.99 | -0.20 | -1.5% | $13.25 | $13.35 | $12.77 | 1,579,100 | |
| $13.19 | -0.48 | -3.5% | $13.43 | $13.63 | $12.76 | 3,025,700 | |
| $13.67 | -1.18 | -7.9% | $14.84 | $14.84 | $13.51 | 2,741,100 | |
| $14.85 | +0.63 | +4.4% | $14.42 | $14.97 | $14.22 | 2,431,900 | |
| $14.22 | +0.60 | +4.4% | $13.90 | $14.49 | $13.56 | 3,293,300 | |
| $13.62 | -0.27 | -1.9% | $14.07 | $14.37 | $13.46 | 6,431,800 | |
| $13.89 | +1.87 | +15.6% | $12.18 | $14.33 | $12.05 | 5,833,704 | |
| $12.02 | -0.32 | -2.6% | $12.34 | $12.44 | $11.93 | 2,253,000 | |
| $12.34 | -0.30 | -2.4% | $12.57 | $12.67 | $11.96 | 3,082,200 | |
| $12.64 | -0.07 | -0.6% | $12.52 | $12.87 | $12.52 | 1,648,600 | |
| $12.71 | -0.08 | -0.6% | $13.03 | $13.37 | $12.58 | 2,862,300 | |
| $12.79 | -2.21 | -14.7% | $13.53 | $13.84 | $12.44 | 8,321,300 | |
| $15.00 | +0.28 | +1.9% | $14.62 | $15.46 | $14.42 | 2,817,100 | |
| $14.72 | -0.97 | -6.2% | $14.91 | $15.80 | $14.33 | 3,306,300 | |
| $15.69 | -0.17 | -1.1% | $15.52 | $15.81 | $15.21 | 1,900,800 | |
| $15.86 | +0.17 | +1.1% | $15.89 | $16.29 | $15.46 | 2,258,700 | |
| $15.69 | -0.05 | -0.3% | $15.97 | $16.66 | $14.98 | 2,677,400 | |
| $15.74 | +0.47 | +3.1% | $15.39 | $16.04 | $14.88 | 2,480,100 | |
| $15.27 | -0.14 | -0.9% | $15.46 | $15.79 | $15.18 | 2,926,700 | |
| $15.41 | -0.71 | -4.4% | $15.88 | $16.34 | $14.94 | 2,887,900 | |
| $16.12 | -0.83 | -4.9% | $16.95 | $17.05 | $15.50 | 5,426,500 | |
| $16.95 | +2.57 | +17.9% | $14.24 | $18.24 | $13.00 | 15,760,200 | |
| $14.38 | +0.70 | +5.1% | $13.96 | $14.86 | $13.92 | 3,441,599 | |
| $13.68 | -0.17 | -1.2% | $13.95 | $14.00 | $13.56 | 1,355,524 | |
| $13.85 | +0.35 | +2.6% | $13.60 | $14.33 | $13.53 | 2,085,900 | |
| $13.50 | -0.64 | -4.5% | $13.96 | $14.52 | $13.26 | 4,017,400 | |
| $14.14 | +0.57 | +4.2% | $13.94 | $14.44 | $13.76 | 1,963,600 | |
| $13.57 | -0.89 | -6.2% | $14.30 | $14.30 | $13.55 | 1,965,200 | |
| $14.46 | -0.18 | -1.2% | $14.50 | $14.79 | $14.22 | 1,849,200 | |
| $14.64 | -0.21 | -1.4% | $14.79 | $14.96 | $14.31 | 1,243,800 | |
| $14.85 | +0.46 | +3.2% | $14.47 | $15.04 | $14.30 | 1,651,800 | |
| $14.39 | -0.10 | -0.7% | $14.63 | $14.75 | $14.18 | 2,139,000 | |
| $14.49 | -0.05 | -0.3% | $14.00 | $14.57 | $13.73 | 2,362,955 | |
| $14.54 | -0.12 | -0.8% | $14.59 | $14.92 | $14.50 | 1,377,761 | |
| $14.66 | +0.24 | +1.7% | $14.77 | $14.93 | $14.44 | 1,121,700 | |
| $14.42 | +0.79 | +5.8% | $13.61 | $14.51 | $13.61 | 1,881,300 | |
| $13.63 | -0.12 | -0.9% | $13.82 | $14.00 | $13.43 | 1,433,200 | |
| $13.75 | +0.38 | +2.8% | $13.66 | $13.79 | $13.32 | 2,414,500 | |
| $13.37 | -0.13 | -1.0% | $13.51 | $13.70 | $13.13 | 1,590,000 | |
| $13.50 | -0.32 | -2.3% | $13.87 | $13.94 | $13.25 | 1,429,800 | |
| $13.82 | +0.39 | +2.9% | $13.50 | $13.87 | $13.13 | 1,242,500 | |
| $13.43 | -0.34 | -2.5% | $13.78 | $14.10 | $13.27 | 1,480,900 | |
| $13.77 | -0.74 | -5.1% | $14.27 | $14.57 | $13.64 | 3,625,600 | |
| $14.51 | +0.19 | +1.3% | $14.62 | $14.89 | $14.25 | 1,873,800 | |
| $14.32 | -0.33 | -2.3% | $14.68 | $14.98 | $13.88 | 1,718,100 | |
| $14.65 | -0.10 | -0.7% | $14.65 | $14.86 | $14.35 | 1,549,200 | |
| $14.75 | -0.76 | -4.9% | $15.26 | $15.50 | $14.56 | 2,169,500 | |
| $15.51 | +0.65 | +4.4% | $15.09 | $15.57 | $14.86 | 1,752,500 |
- Ticker
- NYSE:BHVN
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NYSE
- Currency
- USD
What changed lately
Latest news release · Sep 28, 2026
Biohaven's Clinical Data on BHV-1530, a Novel FGFR3-Directed ADC With a Proprietary Topoisomerase I (TopoIx) Payload, Selected for Oral Presentation at the EORTC-NCI-AACR Symposium 2026
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 84 slides
Calls
Replays
Biohaven (NYSE:BHVN) Q4 2021 Earnings Call
Fri, Feb 25, 2022 · 8:30 AM ET
Watch TranscriptBiohaven (NYSE:BHVN) Q3 2021 Earnings Call
Tue, Nov 09, 2021 · 8:00 AM ET
Watch TranscriptBiohaven (NYSE:BHVN) Q2 2021 Earnings Call
Mon, Aug 09, 2021 · 8:30 AM ET
Watch Transcript
Latest news
Biohaven's Clinical Data on BHV-1530, a Novel FGFR3-Directed ADC With a Proprietary Topoisomerase I (TopoIx) Payload, Selected for Oral Presentation at the EORTC-NCI-AACR Symposium 2026
Sep 28, 2026
Closed $13.27 (+2.2%) on Sep 28, 2026
Biohaven and SK Biopharmaceuticals Enter into Strategic Global Licensing Agreement for Novel Kv7 Ion Channel Platform and Opakalim, Lead Candidate for Epilepsy
Aug 27, 2026
Closed $16.12 (-4.9%) on Aug 27, 2026
Biohaven to Present New Clinical Data at ESMO Congress on BHV-1530, a Novel FGFR3-Directed ADC With a Proprietary Topoisomerase I (TopoIx) Payload
Jul 20, 2026
Closed $14.86 (-3.8%) on Jul 20, 2026
Biohaven Announces Scientific Leadership Transitions
Jul 9, 2026
Closed $15.55 (-7.4%) on Jul 10, 2026
Decks
Investor Presentation (August 2026)
Investor deck · 84 slides · August 2026
44th Annual J.P. Morgan Healthcare Conference (January 2026)
Conference · 45 slides · Jan 12, 2026
J.P. Morgan Healthcare Conference 2026
Conference · 87 slides · Jan 12, 2026
Investor Presentation (June 2025)
Investor deck · 160 slides · Jun 4, 2025
Biohaven Ltd. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 20 in the last 12 months · 39 in all · newest Sep 28, 2026 · oldest 2024
- Calls
- 5 calls with a replay · 5 with a transcript · latest Feb 25, 2022
- Decks
- 12 decks · latest August 2026
Where Biohaven Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE:BHVN · Home listing · This page | NYSE | United States | USD |
| Tradegate:ZH6 | Tradegate | Germany | EUR |
| B3:BHVN34 | B3 | Brazil | BRL |
| BOATS:BHVN | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Biohaven Ltd.